Literature DB >> 6366063

A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions.

C O Elson, W Ealding, J Lefkowitz.   

Abstract

Mouse intestinal secretions can be readily obtained without harm to the mice by administering a lavage solution to them intragastrically followed by pilocarpine intraperitoneally. These secretions are rich in proteases but this enzyme activity can be blocked by addition of a mixture of inhibitors. Both total and specific IgA antibody could be measured in these secretions using ELISA techniques. The total IgA recovered was found to vary considerably, even in the same group of mice sampled on multiple occasions. Specific IgA anti-cholera toxin antibody was easily demonstrable in the intestinal secretions of mice fed cholera toxin but not of mice fed an irrelevant antigen. Expression of the specific IgA antibody per unit of total IgA recovered is desirable in order to correct for the variable recovery of IgA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6366063     DOI: 10.1016/0022-1759(84)90089-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  65 in total

1.  Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.

Authors:  D Externest; B Meckelein; M A Schmidt; A Frey
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Gastrin, somatostatin, and experimental disturbance of the gastrointestinal tract in rats.

Authors:  Y L Yao; B Xu; W D Zhang; Y G Song
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 3.  Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.

Authors:  Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

4.  Involvement of antigen-presenting cells in the enhancement of the in vitro antibody responses by cholera toxin B subunit.

Authors:  Y Hirabayashi; S I Tamura; K Shimada; T Kurata
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

5.  Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.

Authors:  A K Turner; T D Terry; D A Sack; P Londoño-Arcila; M J Darsley
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes.

Authors:  C O Elson
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

7.  Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein.

Authors:  M T Dertzbaugh; D L Peterson; F L Macrina
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  Helicobacter pylori specific immune response induced by conservative flagellin linear B-cell epitope.

Authors:  Wan-Sheng Ji; Jia-Lu Hu; Kai-Chun Wu; Jun-Wen Qiu; Zhe-Yi Han; Jie Ding; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

9.  Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.

Authors:  T K Redman; C C Harmon; S M Michalek
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein.

Authors:  Yigang Xu; Yijing Li
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.